DENTSPLY SIRONA (NASDAQ:XRAY) Reaches New 1-Year Low – Time to Sell?

DENTSPLY SIRONA Inc. (NASDAQ:XRAY) shares hit a new 52-week low on Friday . The stock traded as low as $10.52 and last traded at $10.5750, with a volume of 834181 shares traded. The stock had previously closed at $10.95.

Analysts Set New Price Targets

Several equities research analysts have recently issued reports on XRAY shares. JPMorgan Chase & Co. lowered their target price on shares of DENTSPLY SIRONA from $14.00 to $12.00 and set a “neutral” rating on the stock in a research note on Friday, November 7th. Mizuho set a $13.00 target price on shares of DENTSPLY SIRONA in a report on Friday, November 7th. Zacks Research downgraded shares of DENTSPLY SIRONA from a “hold” rating to a “strong sell” rating in a research note on Monday. Wall Street Zen cut shares of DENTSPLY SIRONA from a “buy” rating to a “hold” rating in a report on Saturday, October 18th. Finally, Wells Fargo & Company dropped their price target on shares of DENTSPLY SIRONA from $15.00 to $12.00 and set an “equal weight” rating on the stock in a research note on Friday, November 7th. Two research analysts have rated the stock with a Buy rating, ten have issued a Hold rating and two have assigned a Sell rating to the stock. According to data from MarketBeat, the stock has a consensus rating of “Hold” and a consensus price target of $16.08.

DENTSPLY SIRONA Stock Down 3.5%

The company has a debt-to-equity ratio of 1.13, a current ratio of 1.69 and a quick ratio of 1.11. The firm has a market cap of $2.11 billion, a PE ratio of -2.23, a PEG ratio of 0.81 and a beta of 1.00. The stock has a 50 day simple moving average of $12.73 and a 200-day simple moving average of $14.40.

DENTSPLY SIRONA (NASDAQ:XRAY) last released its quarterly earnings results on Thursday, November 6th. The medical instruments supplier reported $0.37 earnings per share for the quarter, missing the consensus estimate of $0.45 by ($0.08). The company had revenue of $904.00 million for the quarter, compared to analysts’ expectations of $900.33 million. DENTSPLY SIRONA had a negative net margin of 25.85% and a positive return on equity of 16.33%. The business’s quarterly revenue was down 4.9% on a year-over-year basis. During the same quarter in the previous year, the company posted $0.50 EPS. DENTSPLY SIRONA has set its FY 2025 guidance at 1.600-1.600 EPS. Sell-side analysts predict that DENTSPLY SIRONA Inc. will post 1.84 EPS for the current fiscal year.

Institutional Investors Weigh In On DENTSPLY SIRONA

Large investors have recently added to or reduced their stakes in the company. Envestnet Asset Management Inc. grew its position in shares of DENTSPLY SIRONA by 9.0% in the 1st quarter. Envestnet Asset Management Inc. now owns 494,737 shares of the medical instruments supplier’s stock worth $7,391,000 after buying an additional 40,936 shares during the period. Bank of Montreal Can lifted its stake in shares of DENTSPLY SIRONA by 8.2% during the 2nd quarter. Bank of Montreal Can now owns 352,524 shares of the medical instruments supplier’s stock worth $5,598,000 after purchasing an additional 26,610 shares during the last quarter. Envestnet Portfolio Solutions Inc. raised its stake in DENTSPLY SIRONA by 36.9% in the 2nd quarter. Envestnet Portfolio Solutions Inc. now owns 15,460 shares of the medical instruments supplier’s stock worth $246,000 after acquiring an additional 4,165 shares during the last quarter. AGF Management Ltd. raised its position in DENTSPLY SIRONA by 29.6% during the second quarter. AGF Management Ltd. now owns 186,424 shares of the medical instruments supplier’s stock worth $2,960,000 after acquiring an additional 42,542 shares during the period. Finally, Dynamic Technology Lab Private Ltd acquired a new position in DENTSPLY SIRONA in the 1st quarter valued at about $366,000. 95.70% of the stock is owned by institutional investors and hedge funds.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.